The prescribing pattern of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in patient with type two diabetes mellitus: A two-center retrospective cross-sectional study

The prescribing pattern of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in patient with type two diabetes mellitus: A two-center retrospective cross-sectional study

BackgroundThe use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RA) in patients with type 2 diabetes mellitus (T2DM) remains limited, especially in those with other compelling indications. Thus, this study aimed to describe the prescribing...

Full description

Bibliographic Details
Main Authors: Ghazwa B. Korayem, Omar A. Alshaya, Albandari A. Alghamdi, Shahad S. Alanazi, Renad T. Almutib, Mahdi Alsaileek, Abdulrahman Alrashidi, Nasser Aldosari, Nader Bin Sheraim, Majed S. Al Yami, Omar A. Almohammed
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Public Health
Subjects:
type 2 diabetes
underprescription
sodium-glucose cotransporter-2 inhibitors
glucagon-like peptide-1 receptor agonists
comorbidities
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.1031306/full

Internet

https://www.frontiersin.org/articles/10.3389/fpubh.2022.1031306/full

Similar Items